Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307664![]() (2-(6-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)pyridin-...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307665![]() (2-(6-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)pyridin-...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307666![]() (2-(6-(4-cyclopropyl- 4H-1,2,4-triazol-3- yl)pyridi...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307667![]() (2-(6-(4-cyclopropyl- 4H-1,2,4-triazol-3- yl)pyridi...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307668![]() (2-(6-(4-cyclopropyl- 4H-1,2,4-triazol-3- yl)pyridi...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Myosin light chain kinase, smooth muscle (Homo sapiens (Human)) | BDBM307668![]() (2-(6-(4-cyclopropyl- 4H-1,2,4-triazol-3- yl)pyridi...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description MYLK dissociation constants (Kd) for compounds were determined using the DiscoverX KdELECT platform. The MYLK kinase (accession number NP_444254.3) w... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307654![]() (2-(6-(4-cyclopropyl- 4H-1,2,4-triazol-3- yl)pyridi...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307670![]() (6-(4-cyclopropyl-1H-1,2,3-triazol-1-yl)-2-(6-(4-cy...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307671![]() (2-(6-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)pyridin-...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307672![]() (2-(6-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)pyridin-...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Myosin light chain kinase, smooth muscle (Homo sapiens (Human)) | BDBM307672![]() (2-(6-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)pyridin-...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description MYLK dissociation constants (Kd) for compounds were determined using the DiscoverX KdELECT platform. The MYLK kinase (accession number NP_444254.3) w... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307673![]() (5-chloro-2-(6-(4-cyclopropyl-4H-1,2,4-triazol-3-yl...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307674![]() (2-(6-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)pyridin-...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Myosin light chain kinase, smooth muscle (Homo sapiens (Human)) | BDBM307674![]() (2-(6-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)pyridin-...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description MYLK dissociation constants (Kd) for compounds were determined using the DiscoverX KdELECT platform. The MYLK kinase (accession number NP_444254.3) w... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307675![]() (2-(6-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)pyridin-...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307676![]() (2-(6-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)pyridin-...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307677![]() (US10150755, Compound 69) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307678![]() (2-(6-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)pyridin-...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307679![]() (2-(6-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)pyridin-...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307680![]() (US10150755, Compound 72 | methyl 2-(6-(4-cycloprop...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307681![]() (2-(6-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)pyridin-...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307686![]() (2-(6-(5-methyl-6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Myosin light chain kinase, smooth muscle (Homo sapiens (Human)) | BDBM307686![]() (2-(6-(5-methyl-6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description MYLK dissociation constants (Kd) for compounds were determined using the DiscoverX KdELECT platform. The MYLK kinase (accession number NP_444254.3) w... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307687![]() ((R)-2-(6-(5-(hydroxymethyl)-6,7-dihydro-5H-pyrrolo...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307690![]() (US10150755, Compound 82) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307691![]() (2-(6-(5-cyclopropyl-1H-1,2,3-triazol-1-yl)pyridin-...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307693![]() (2-(6-(4-isopropyl-4H-1,2,4-triazol-3-yl)pyridin-2-...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307609![]() (2-(6-(4-Cyclopropyl-4H-1,2,4-triazol-3-yl)pyridin-...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Myosin light chain kinase, smooth muscle (Homo sapiens (Human)) | BDBM307609![]() (2-(6-(4-Cyclopropyl-4H-1,2,4-triazol-3-yl)pyridin-...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description MYLK dissociation constants (Kd) for compounds were determined using the DiscoverX KdELECT platform. The MYLK kinase (accession number NP_444254.3) w... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307682![]() (2-(6-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)pyridin-...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307610![]() (2-(6-(4-Cyclopropyl-4H-1,2,4-triazol-3-yl)pyridin-...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307612![]() (2-(6-(4-cyclopropyl- 4H-1,2,4-triazol-3- yl)pyridi...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307613![]() (N-(2-(1H-imidazol- 1-yl)ethyl)-2-(6-(4- cyclopropy...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307614![]() (2-(6-(4-cyclopropyl- 4H-1,2,4-triazol-3- yl)pyridi...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307615![]() (2-(6-(4-cyclopropyl- 4H-1,2,4-triazol-3- yl)pyridi...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307616![]() (N-cyclopropyl-2-(6- (4-cyclopropyl-4H- 1,2,4-triaz...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307617![]() (2-(6-(4-cyclopropyl- 4H-1,2,4-triazol-3- yl)pyridi...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307618![]() (2-(6-(4-cyclopropyl- 4H-1,2,4-triazol-3- yl)pyridi...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307619![]() (2-(6-(4-cyclopropyl- 4H-1,2,4-triazol-3- yl)pyridi...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | Purchase PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307620![]() (2-(6-(4-cyclopropyl- 4H-1,2,4-triazol-3- yl)pyridi...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307621![]() (2-(6-(4-cyclopropyl- 4H-1,2,4-triazol-3- yl)pyridi...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307622![]() (2-(6-(4-cyclopropyl- 4H-1,2,4-triazol-3- yl)pyridi...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307623![]() (2-(6-(4-cyclopropyl- 4H-1,2,4-triazol-3- yl)pyridi...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307624![]() (5-(4- acetylpiperazine-1- carbonyl)-2-(6-(4- cyclo...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307625![]() (N-(1-(2-(6-(4- cyclopropyl-4H- 1,2,4-triazol-3- yl...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307626![]() (2-(6-(4-cyclopropyl- 4H-1,2,4-triazol-3- yl)pyridi...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307627![]() (5-(azetidine-1- carbonyl)-2-(6-(4- cyclopropyl-4H-...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307628![]() (2-(6-(4-cyclopropyl- 4H-1,2,4-triazol-3- yl)pyridi...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307629![]() (5-((1R,5S)-8-oxa-3- azabicyclo[3.2.1] octane-3-car...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM307630![]() ((R)-2-(6-(4- cyclopropyl-4H- 1,2,4-triazol-3- yl)p...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | <200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SEAL ROCK THERAPEUTICS, INC. US Patent | Assay Description The ASK1 enzymatic assay was run following Promega ASK1 Kinase Enzyme System (Cat #V3881). The kit provides the protocol, enzymes and all reagents ne... | US Patent US10150755 (2018) BindingDB Entry DOI: 10.7270/Q2125VQ8 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 127 total ) | Next | Last >> |